Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 21,174† | 23,373† | 20,741† | 21,091† | 16,194† |
| Net profit | 2,623 | 4,283 | 2,858 | 1,691 | 458† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Aalok Dilip Shanghvi | Executive Director | June 30, 2026 |
| Dilip Shantilal Shanghvi | Executive Director | June 30, 2026 |
| Kirti Wardhaman Ganorkar | Executive Director | June 30, 2026 |
| Vidhi Dilip Shanghvi | Executive Director | June 30, 2026 |
| Andreas Busch | Independent Director | June 30, 2026 |
| Gautam Bhailal Doshi | Independent Director | June 30, 2026 |
| Pawan Kumar Goenka | Independent Director | June 30, 2026 |
| Rolf Hoffmann | Independent Director | June 30, 2026 |
| Satyavati Berera | Independent Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
